Xiaoqi ZhaoI; Tianxiang GuII; Zongyi XiuI; Enyi ShiII; Lei YuI
OBJECTIVE: To summarize the effect of mild hypothermia on function of the organs in patients with multiple organ dysfunction syndrome after cardiopulmonary bypass surgery.
METHODS: The patients were randomly divided into two groups, northermia group (n=71) and hypothermia group (n=89). We immediately began cooling the hypothermia group when test results showed multiple organ dysfunction syndrome, meanwhile all patients of two groups were drawn blood to test blood gas, liver and kidney function, blood coagulation function, and evaluated the cardiac function using echocardiography from 12 to 36 hours. We compared the difference of intra-aortic balloon pump, extracorporeal membrane oxygenation rate and mortality within one month after intensive care unit admission.
RESULTS: Among the 160 patients, 36 died, 10 (11.24%) patients were from the hypothermia group and 26 (36.6%) from the northermia group (P<0.05). In northermia group, 45 (63.38%) patients used intra-aortic balloon pump and 4 (5.63%), extracorporeal membrane oxygenation; in hypothermia group, 35 (39.32%) patients used intra-aortic balloon pump and 2 (2.25%), extracorporeal membrane oxygenation( P<0.05). The patients' heart rate decreased significantly in the hypothermia group. The heart rate of hypothermia group is significantly slower than the northermia group at the 36th hour (P<0.05). But the mean arterial pressure of hypothermia group is significantly higher than the northermia group at the 36th hour (P<0.05). In hypothermia group, PO2, SvO2 and lactate were improved significantly compared to pre-cooling (P<0.05), and they were significantly better than the northermia group at the 36th hour (P<0.05%). Prothrombin time and activated partial thromboplastin time have no significantly difference between the two groups (P>0.05). But the platelet count has significantly difference between the two groups at the 36th hour (P<0.05). The aspartate transaminase, alanine transaminase and creatinine were improved significantly in the hypothermia group, and they were significantly better than the northermia group (P<0.05).
CONCLUSION: Mild hypothermia is feasible and safe for patients with multiple organ dysfunction syndrome after cardiopulmonary bypass surgery.
ALB = Albumin
ALT = Alanine transaminase
APTT = Activated partial thromboplastin time
AST = Aspartate transaminase
ATP = Adenosine triphosphate
BSA = Body surface area
CI = Cardiac index
CPB = Cardiopulmonary bypass
ECMO = Extracorporeal membrane oxygenation
Emax = Ventricular end-systolic maximum elastance
HR = Heart rate
HT = Hypothermia group
IABP = Intra-aortic balloon pump
ICU = Intensive Care Unit
LCOS = Low cardiac output syndrome
MAP = Mean arterial pressure
MODS = Multiple organ dysfunction syndrome
NT = Northermia group
PLT = Platelet count
PT = Prothrombin time
PVA = Pressure-volume area
SIRS = Systemic inflammatory response syndrome
SV = Stroke volume
Multiple organ dysfunction syndrome (MODS) is defined as "the presence of altered organ function in an acutely ill patient such that homeostasis cannot be maintained with intervention". It is a cause of high mortality and morbidity in Intensive Care Unit (ICU). Many advances have been made in the treatment of MODS. Hypothermia has become an established therapeutic concept in the treatment of cardiovascular and neurological diseases, and it has shown myocardial and neurological protection, yet the benefits for MODS after cardiac surgery have not been well defined. We hypothesized that mild hypothermia has organ protective effects and can ameliorate organ dysfunction to improve the survival rate for the patients with MODS after cardiopulmonary bypass (CPB) cardiac surgery.
The study was designed as prospective unblended intervention trial where patients served as their own controls. This study protocol was approved by the ethics committee of the First Affiliated Hospital of China Medical University. The patients with MODS after cardiac surgery underdoing CPB from May 2011 to February 2015 were screened for this study. The cardiac function of all the patients was class II-III (New York Heart Association).
Exclusion criteria: patients with respiratory, nervous, hematological system diseases or liver, kidney, digestive system diseases before surgery; patients with massive blood transfusion (massive blood transfusion defined as the replacement of a patients' total blood volume in less than 24 hours, or as the acute administration more than half the patients' estimated blood volume per hour); patients died within 24 hours after ICU admission.
The MODS diagnosis criterion of MODS is shown in Table 1.
All the patients used urine catheter with temperature probe by which we can monitore the patients' bladder temperature. At the admission to Cardiac Surgery ICU, the patients were assisted by ventilator, tidal volume (ml) = Body weight (kg)*10(ml/kg); respiratory frequency 12-14 times/min; FiO2:0.50-0.75. At the same time, intravenous sedation and muscular relaxation agent were infused. We used the echocardiography to monitor cardiac stroke volume (SV), then we calculated cardiac index (CI), CI=heart rate (HR)*SV/body surface area (BSA).
The basic treatments for the patients of the two groups are same, including intravenous infusion of vasoactive agents to maintain hemodynamic stability and improve organs function. However, in the hypothermia group (HT), hypothermia treatment was implemented by a computer cooling blanket (CJ1 temperature lowering instrument). The patient was placed on the blanket which is filled with the variable temperature cycle of cryogenic mat. We adjusted the temperature of cooling blanket until the patients' bladder temperature reached and maintained 35ºC. The cooling rate was about 1.0ºC/h. The bladder temperature was reduced from 36.1ºC±0.2ºC to 33.1ºC±0.1ºC within 168±10min of starting cooling and remained lowered at 32.9±0.5ºC during 36 hours.
If patients' postoperative test results (we marked it as precooling) showed two or more abnormal organ function, we considered the existence of MODS. The patients were randomly divided into two groups, one is northermia group (NT) n=71, the other one is HT (hypothermia group) n=89. Then we immediately began cooling the HT (we marked the time as 0h), meanwhile all patients were drawn arterial blood and venous blood to test blood gas, liver and kidney function, blood coagulation function, and evaluated the cardiac function using echocardiography from 12 to 36 hours. We monitored each patient closely about the parameters of vital signs: mean arterial pressure (MAP), HR, urinary volume.
All statistical analysis were performed using SPSS 17.0, measurement data of each group were performed using normality test, F-test and tested with Rank test.
Among the 160 patients considered for inclusion, 36 died, 10 (11.24%) patients were from the HT and 26 (36.6%) were from the NT (P<0.05). In NT, there were 45 patients who used IABP = Intra-aortic balloon pump (63.38%), 4 patients who used extracorporeal membrane oxygenation (ECMO) (5.63%). In HT, there were 35 patients who used IABP (39.32%), 2 (2.25%) patients ECMO (P<0.05). The patients' HR decreased significantly after the application of hypothermia. The HR difference between the two groups at the 36th hour is significant (P<0.05), shown as Figure 1. The MAP of HT is lower than NT significantly at 0 hour, because we used the sedation and muscular relaxation agent, and the depth of sedation in HT is much more deeply than NT in order to prevent chill. But the MAP of HT is significantly higher than NT after hypothermia at the 36th hour (P<0.05), shown as Figure 2. PO2, SvO2, lactate and CI have no significantly difference between the two groups pre-cooling (P>0.05). In HT group, PO2, SvO2 and lactate were improved significantly at the 36th hour compared with pre-cooling (P<0.05), and they were better than NT group significantly at the 36th hour (P<0.05%) as shown in Table 2. Prothrombin time (PT) and activated partial thromboplastin time (APTT) have no significantly difference between the two groups (P>0.05). But the platelet count (PLT) has significantly difference between the two groups at the 36th hour (P<0.05%), shown in Table 3. The aspartate transaminase (AST), alanine transaminase (ALT) and creatinine were improved significantly in the HT group, and they were significantly better than the NT group (P<0.05), shown in Table 4.
The first major finding of the present study is that the induction of mild hypothermia until the 36th hour is feasible and safe for patients with MODS after CPB. There are several proposed mechanisms for the development of MODS, including:(1) cell or tissue hypoxia; (2) induction of cellular apoptosis; (3) translocation of microbes or components of microbes from the gastrointestinal tract; (4) immune system dysregulation, and (5) mitochondrial dysfunction. The predominant failure organs involved in MODS are hepatic, respiratory, gastrointestinal, cardiovascular, coagulation, renal, central nervous and endocrine systems. Most cardiac surgery need CPB, but intra-operation of cardiac surgery, CPB can lead to a variety of inflammatory medium content increased significantly. As a result abnormal cytokine expression and systemic inflammatory reaction in tissues impaired the organs function, and even lead to further multiple organ dysfunction.
Hypothermia can be divided into mild hypothermia (32-35ºC), moderate hypothermia (28-32ºC), deep hypothermia (20-28ºC), super-deep hypothermia (<20ºC). Many studies have shown that mild hypothermia interference with the body's homeostasis is not significant. It can decrease the oxygen consumption of the tissue, delay the adenosine triphosphate (ATP) consumption when tissue is ischemia. The mild hypothermia can improve the organization of ischemia hypoxia tolerance, so that the organization oxygen can achieve balance between supply and demand, maintain each organ function. It reduces metabolic demand and high energy phosphate utilization in the myocardium[13-15], it is advantageous to oxygen uptake and utilization of the heart cells. At the same time, mild hypothermia can avoid ventricular fibrillation which may be caused by deep hypothermia, and Bernard et al. have discovered the incidence of infection is not common in short term hypothermia treatment (12-36 hours), so we chose the mild hypothermia for 36 hours in this study.
Some studies have shown that mild hypothermia inhibits inflammation reaction, inhibit the release and expression of TNF-alpha and ICAM-1, and protect the organ function. In the hypothermia application process, it should be fully realized the side effect as its influence on blood coagulation function and so on. But in our study, we did not observe any complication of clinical relevance associated with mild hypothermia, especially bleeding, thrombosis, arterial or pulmonary embolism and no adverse haemodynamic events. Rodriguez et al. showed that, in the case of patients with chill, oxygen consumption will increase by 45%. Frank et al. found that for patients with a history of myocardial ischemia, chill increased the risk of myocardial infarction, so we should use sedation and neuromuscular blockade to anti-shiver in the duration of hypothermia.
The second major finding is that moderate hypothermia significantly improves parameters of organ function in the patients with MODS after CPB surgery. Low cardiac output syndrome (LCOS) is a predominant cause of the MODS after cardiac surgery, meanwhile, MODS may lead to cardiovascular dysfunction characterized by biventricular dilatation, decreased ejection fraction and hypotension. Then MODS may lead to form a vicious circle, and make the condition worse. So, in order to treat the MODS after cardiac surgery, correcting heart function effectively is the most important. Because of the improvement of cardiac function, the perfusion of the other organs was improved and the organ functions were improved further. As cardiac power output predicts mortality during LCOS, our data indicate that the improvement to the patients with MODS after CPB surgery in the hypothermia group may in part be related to improved cardiac performance. In a situation of severely depressed left ventricle function, cooling may improve systemic oxygen supply-demand balance not only by reducing demand but also by increasing cardiac output via its positive inotropic effect. The positive inotropic effect of hypothermia has been confirmed by Gotberg et al. using whole-animal models of cardiogenic shock. The inotropic effect of hypothermia is associated with an effect at the level of myofilaments, without causing changes in sarcoplasmatic calcium content or intracellular calcium concentration. This implies that hypothermia can recruit a contractile reserve without increasing energy demand. In the acute myocardial infarction model, therapeutic hypothermia has been proved that it improves myocardial dysfunction by reducing ischemia-reperfusion injury and results in a decreased size of infarction[26,27]. Ristagno et al. studied the effect of hypothermia on ventricular myocyte contractility, and discovered that hypothermia increased ventricular myocyte contractility either under conditions of normal perfusion or after perfusion following a 10 min interval of ischemia. Shattock & Bers and Miao & Lynch showed that hypothermia increases in myocardial force generation and this was confirmed by Fukunami & Hearse and Nishimura et al.. Suga et al. resported that cardiac cooling increased ventricular end-systolic maximum elastance (Emax) without affecting systolic pressure-volume area (PVA)-independent VO2 and has energetically more advantages in saving myocardial oxygen-consumption compared to catecholamine in cross circulated canine heart preparations.
Some limitations of our study should be acknowledged. Firstly, this study was designed as a prospective unblended intervention trial, so there is a chance that sicker patients might have been considered for normothermia. But in our study, the initial parameters have no significant differences between the two groups. So the authors think the potential bias induced by that is limited. Another limitation is the information on temperature. We recorded the time in which TH was reached, but we didn't document the course of the temperature during rewarming. Thus, maybe further research is needed to identify the effect of the course of rewarming on mortality.
In summary, our studies demonstrate that mild hypothermia is feasible and safe also for patients with MODS after CPB surgery. Mild hypothermia can improve the organ function effectively, and improve the morbidity and mortality of the patients. It can slow the MODS/Systemic inflammatory response syndrome (SIRS) development speed and reduce the time of protection and further treatment for cells and organs.
1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20(6):864-74. [MedLine]
2. Umegaki T, Ikai H, Imanaka Y. The impact of acute organ dysfunction on patients' mortality with severe sepsis. J Anaesthesiol Clin Pharmacol. 2011;27(2):180-4. [MedLine]
3. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD; Joint ESC/ACCF/AHA/WHF Task Force for Universal Definition of Myocardial Infarction; Authors/Task Force Members Chairpersons, ECG Subcommittee, Imaging Subcommittee, Classification Subcommittee, Intervention Subcommittee, Trials & Registries Subcommittee, ESC Committee for Practice Guidelines (CPG). Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60(16):1581-98. [MedLine]
4. Shuwen Z, Chao W. Multi-center studies about the criterion of MODS. Chin J Surg. 2009;47(1):40-5.
5. Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002;346(8):549-56. [MedLine]
6. Osterbur K, Mann FA, Kuroki K, DeClue A. Multiple organ dysfunction syndrome in humans and animals. J Vet Intern Med. 2014;28(4):1141-51. [MedLine]
7. Khadaroo RG, Marshall JC. ARDS and the multiple organ dysfunction syndrome. Common mechanisms of a common systemic process. Crit Care Clin. 2002;18(1):127-41. [MedLine]
8. Morariu AM, Loef BG, Aarts LP, Rietman GW, Rakhorst G, van Oeveren W, et al. Dexamethasone: benefit and prejudice for patients undergoing on-pump coronary artery bypass grafting: a study on myocardial, pulmonary, renal, intestinal, and hepatic injury. Chest. 2005;128(4):2677-87. [MedLine]
9. Sablotzki A, Friedrich I, Mühling J, Dehne MG, Spillner J, Silber RE, et al. The systemic inflammatory response syndrome following cardiac surgery: different expression of proinflammatory cytokines and procalcitonin in patients with and without multiorgan dysfunctions. Perfusion. 2002;17(2):103-9. [MedLine]
10. Tissier R, Chenoune M, Ghaleh B, Cohen MV, Downey JM, Berdeaux A. The small chill: mild hypothermia for cardioprotection? Cardiovasc Res. 2010;88(3):406-14. [MedLine]
11. Birdi I, Caputo M, Underwood M, Angelini GD, Bryan AJ. Influence of normothermic systemic perfusion temperature on cold myocardial protection during coronary artery bypass surgery. Cardiovasc Surg. 1999;7(3):369-74. [MedLine]
12. Lewis ME, Al-Khalidi AH, Townend JN, Coote J, Bonser RS. The effects of hypothermia on human left ventricular contractile function during cardiac surgery. J Am Coll Cardiol. 2002;39(1):102-8. [MedLine]
13. Gilbert NF, Meyer PE, Tauriainen MP, Chao RY, Patel JB, Malloy CR, et al. Effects of hypothermia on myocardial substrate selection. Ann Thorac Surg. 2002;74(4):1208-12. [MedLine]
14. Buckberg GD, Brazier JR, Nelson RL, Goldstein SM, McConnell DH, Cooper N. Studies of the effects of hypothermia on reginal myocardial blood flow and metabolism during cardiopulmonary bypass-I. The adequately perfused beating, fibrillating, and arrested heart. J Thorac Cardiovasc Surg. 1977;73(1):87-94. [MedLine]
15. Ning XH, Xu CS, Portman MA. Mitochondrial protein and HSP70 signaling after ischemia in hypothermic-adapted hearts augmented with glucose. Am J Physiol. 1999;277(1 Pt 2):R11-7. [MedLine]
16. Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002;346(8):557-63. [MedLine]
17. Rodriguez JL, Weissman C, Damask MC, Askanazi J, Hyman AI, Kinney JM. Physiologic requirements during rewarming: suppression of the shivering response. Crit Care Med. 1983;11(7):490-7. [MedLine]
18. Frank SM, Fleisher LA, Breslow MJ, Higgins MS, Olson KF, Kelly S, et al. Perioperative maintenance of normothermia reduces the incidence of morbid cardiac events. A randomized clinical trial. JAMA. 1997;277(14):1127-34. [MedLine]
19. Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah A. Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: should current practice be changed? J Thorac Cardiovasc Surg. 2003;125(6):1438-50. [MedLine]
20. Hoesel LM, Niederbichler AD, Ward PA. Complement-related molecular events in sepsis leading to heart failure. Mol Immunol. 2007;44(1-3):95-102. [MedLine]
21. Tan LB. Cardiac pumping capability and prognosis in heart failure. Lancet. 1986;2(8520):328:1360-3.
22. Alessio A, Martin M, Michael S, Birgit Z, Paul S, Jochen V, et al. Inotropic effects of experimental hyperthermia and hypothermia on left ventricular function in pigs-comparison with dobutamine. Crit Care Med. 2016;44(3):e158-67. [MedLine]
23. Götberg M, van der Pals J, Olivecrona GK, Götberg M, Koul S, Erlinge D. Mild hypothermia reduces acute mortality and improves hemodynamic outcome in a cardiogenic shock pig model. Resuscitation. 2010;81(9):1190-6. [MedLine]
24. Kusuoka H, Ikoma Y, Futaki S, Suga H, Kitabatake A, Kamada T, et al. Positive inotropism in hypothermia partially depends on an increase in maximal Ca(2+)-activated force. Am J Physiol. 1991;261(4 Pt 2):H1005-10. [MedLine]
25. Weisser J, Martin J, Bisping E, Maier LS, Beyersdorf F, Hasenfuss G, et al. Influence of mild hypothermia on myocardial contractivity and circulatory function. Basic Res Cardiol. 2001;96(2):198-205. [MedLine]
26. Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002;346(8):549-56. [MedLine]
27. Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002;346(8):557-63. [MedLine]
28. Ristagno G, Tantillo S, Sun S, Weil MH, Tang W. Hypothermia improves ventricular myocyte contractility under conditions of normal perfusion and after an interval of ischemia. Resuscitation. 2010;81(7):898-903. [MedLine]
29. Shattock MS, Bers DM. Inotropic response to hypothermia and temperature-dependence of ryanodine action in isolated rabbit and rat ventricular muscle: implications for excitation-contraction coupling. Circ Res. 1987;61(6):761-71. [MedLine]
30. Miao N, Lynch C 3rd. Effect of temperature on volatile anesthetic depression of myocardiac contractions. Anesth Analg. 1993;76(2):366-71. [MedLine]
31. Fukunami M, Hearse DJ. The intropic consequences of cooling: studies in the isolated rat heart. Heart Vessels. 1989;5(1):1-9. [MedLine]
32. Nishimura Y, Naito Y, Nishioka T, Okamura Y. The effects of cardiac cooling under surface-induced hypothermia on the cardiac function in the in situ heart. Interact Cardiovasc Thorac Surg. 2005;4(2):101-5. [MedLine]
33. Suga H, Goto Y, Igarashi Y, Yasumura Y, Nozawa T, Futaki S, et al. Cardiac cooling increases Emax without affecting relation between O2 consumption and systolic pressure-volume area in dog left ventricle. Circ Res. 1998;63(1):61-71.
No financial support.
No conflict of interest.
Authors' roles & responsibilities
XZ Final manuscript approval
TG Conception and design study; final manuscript approval
ZX Statistical analysis; final manuscript approval
ES Manuscript redaction or critical review of its content; final manuscript approval
LY Statistical analysis; final manuscript approval
Article receive on Tuesday, January 5, 2016